Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease
Metastatic disease accounts for more than 90% of deaths from breast cancer. Yet the factors that trigger metastasis, often years after primary tumor removal, are not understood well. Recently the proinflammatory cytokine interleukin- (IL-) 17 family has been associated with poor prognosis in breast...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|